Chronic sinusitis is a common affliction that affects an estimated 37 million Americans each year. The condition is marked by inflammation of the sinuses that block the nasal passages, causing chronic infections. Symptoms include nasal congestion, sinus pain and pressure, loss of smell and taste, nasal discharge, headache, fatigue and depression.<\/p>\n\n\n\n
Medications may provide temporary relief, but sometimes their effectiveness over the long term is not very impressive, prompting many patients to turn to surgery that involves enlarging the sinus openings responsible for drainage. While sinus surgery is effective at relieving symptoms, some patients contend with recurrent sinus infections within a year. At that point, they may opt for follow-up surgery, and the process can repeat itself.<\/p>\n\n\n\n
The PROPEL steroid-releasing implant is an alternative treatment for patients experiencing chronic sinus infections. It is the first (and only) product on the market that targets the inflamed sinus tissues directly, opening them up for improved drainage and a reduction in symptoms.<\/p>\n\n\n\n
The implant, inserted during an endoscopic sinus procedure or a simple office procedure, resembles an expandable cardiac stent and it delivers a measured dose of mometasone furoate, an anti-inflammatory steroid that gradually dissolves. It is completely absorbed by the body four to six weeks after implantation.<\/p>\n\n\n\n
Approved by the FDA in 2013, PROPEL is safe and effective and carries fewer risks of post-surgical scarring or inflammation. Patients typically have a smaller chance of requiring follow-up surgery.<\/p>\n\n\n\n
LATERA is a nasal implant that supports the cartilage on the sidewall of the nose. When patients breathe in through their noses, it is common to see some collapse of the nostril on deep breaths. Sometimes the nostril with underlying cartilage becomes excessively floppy, and the nose collapses with normal breathing. Supporting this cartilage may lead to better breathing by reducing nasal airway obstruction. An ENT will place the absorbable implant inside the nose.\u00a0 It is most typically performed in the office under local anesthesia.\u00a0\u00a0<\/p>\n\n\n\n
90% of LATERA patients were satisfied with their breathing after the procedure. If you are bothered by chronic sinusitis or nasal congestion and are looking for a long-term solution, schedule an appointment with one of our physicians to learn if one of these implants is a viable option for you.<\/p>\n\n\n\n
\r\nCall St. Cloud Ear, Nose & Throat for more information or to schedule an appointment.<\/span>\r\n(320) 252-0233<\/span><\/a>\r\n